|
7/1/98 BIBLIOGRAPHY- NICOTINE prepared by Alison R. Jones, MD
U.S Department of Health and Human Services: Clinical Practice Guideline No 18: Smoking Cessation. Washington, DC, U.S. Government Printing Office, 1996 Pierce JP: Trends in smoking in the United States: projections to the year 2000. JAMA 261:61-65, 1989 U.S. Centers for Disease Control and Prevention. Cigarette smoking attributable mortality and years of potential life lost - United States, 1993. MMWR 1993;42:645-649 Fiore MC, Newcomb P, McBride P: Natural history and epidemiology of tobacco use and addiction. In: Orleans CT, Slade J, eds. Nicotine addiction: principles and management. New York: Oxford University Press 245-261, 1993 Hughes JR, Gust SW, Pechacek TF: Prevalence of tobacco dependence and withdrawal. American Journal of Psychiatry. 144(2):205-8, 1987
Curry SJ: Self-help interventions for smoking cessation. J Consult Clin Psychol 61: 790-803, 1993 Bierner L, Abrams D: The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol 10: 360-365, 1991 Heatherton T, Kozlowski L, Frecker R, et al: The Fagerstrom test for nicotine dependence: a revision of the Fagersreom Tolerance Questionnaire. British Journal of Addictions 86: 1119-1127, 1991 Manley MW, Epps RP, Glynn TJ: The clinician’s role in promoting smoking cessation among clinic patients (Review 30 refs) Medical Clinics of North America 76 (2): 477-94, 1992 Coletti G, Supnick JA, Payne TJ: The smoking self-efficacy questionnaire (SSEQ): preliminary scale development and validation. Behavioral Assessment 7: 249-260, 1985
Psychologic Goldstein MG, Niaura R, Willey-Lessue C, et al: Physicians counseling smokers. A population-based survey of patient’s perceptions of health care provider-delivered smoking cessation interventions. Archives of Int Med 157 (12): 1313-9, 1997 Rigotti NA, Arnsten JH, McKool KM, et al: Efficacy of a smoking cessation program for hospital patients. Arch Int Med 157 (22): 2653-60, 1997 Agency for Health Care Policy and Research: Smoking cessation clinical practice guidelines. JAMA 275: 1270-1280, 1996 Law M, Tang JL: An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Int Med 155: 1933-1941, 1995 Goldstein MG: Treatment of patients with nicotine dependence. Abstracts of Clinical Care Guidelines 9: 23, 1997 Prochaska JO, DiClemente CC: Process of smoking cessation: implications for clinicians. Clin Chest Med 12: 727-735, 1991 West RJ: Psychology and pharmacology in cigarette withdrawal. Jour Psychosomatic Res 28 (5): 379-86, 1984 Pharmacological Hughes JR: Dependence potential and abuse liability of nicotine replacement therapies. Biomed Pharmacother 43: 11-17, 1989 Balfour DJK, Fagerstrom KO: Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther 72: 51-81, 1996 Fagerstrom KO: Review of nicotine gum and tailoring treatment to different types of smokers. Journal of Smoking-Related Disease 5 (suppl 1): 179-182, 1994 Hilleman DE: Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation. J Clin Pharmacol 34: 222-224, 1994 Hurt RD: A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337: 1195-1202, 1997 Puska, P: Is combined use of nicotine patch and gum better than gum alone in smoking cessation? Tobacco Control 4: 231-235, 1995 Schneider NG: Efficacy of buspirone in smoking cessation: a placebo-controlled trial. Clin Pharmacol Ther 60: 568-575, 1996a Schneider NG: Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 91: 1293-1306, 1996b Schuh KJ: Nicotine nasal spray and vapor inhaler: abuse liability assessment. Psychopharmacology 130: 352-361, 1997 Stapleton JA, Russell MA, Feyerabend C, et al: Dose effects and predictors of outcome in randomized trial of transdermal nicotine patches in general practice. Addiction 90 (1): 31-42, 1995 Rose JE, Behm FM, Westman EC, et al: Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 56: 86-99, 1994 Schneider NG, Lunell E, Olmstead RE, Fagerstrom KO: Clinical pharmacokinetics of nasal nicotine delivery: a review and comparison to other nicotine systems. Clin Pharmacokinet 31: 65-80, 1996 Lifrak P, Gariti P, Alterman AI, et al: Results of two levels of adjunctive treatment used with the nicotine patch. Am J Addict 6(2): 93-8, 1997 Goldstein MG: Bupropion sustained release and smoking cessation. [Review] [40refs] Journal of Clinical Psychiatry. 59 Suppl 4:66-72, 1998 Jackson EA: Bupropion for smoking cessation. Journal of Family Practice. 46(2):111-2, 1998
Genetics Eisen SA, Lyons MJ, Goldberg J, True WR: The impact of cigarette and alcohol consumption on weight and obesity. An analysis of 1911 monozygotic male twin pairs. Arch Int Med 153 (21): 2457-63, 1993 Pharmacokinetics Pontieri FE, Tanda G, Orzi F, et al: Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382: 255-257, 1996 Pomerleau OF, Pomerleau CS: Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neurosci Biobehav Rev 8: 503-513, 1984 Clarke PBS, Pert A: Autoradiographic evidence of nicotine receptors on nigrostriatal and mesolimbic dopamine neurons. Brain Res 348: 355-358, 1985 Fowler JS: Brain monoamine oxidase: an inhibition in cigarette smokers. Proc Natl Acad Sci USA 93: 14065-14069, 1996 Lee EW, D’Alonzo GE: Cigarette smoking, nicotine addiction, and its pharmacologic treatment.( Review 109 refs) Arch Int Med 153 (1): 34-48, 1993 Hughes JR, Hatsukami D: Signs and symptoms of tobacco withdrawal. Arch Gen Psy 43 (3): 289-94, 1986 Stolerman IP, Jarvis MJ: The scientific case that nicotine is addictive. Psychopharmacology 117: 2-10, 1995 Benowitz NL, Jacob P: Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther 53: 316-323, 1993 Benowitz NL: Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence. NIDA Res Monogr 99: 12, 1990 Balfour DJK: The neurochemical mechanisms underlying nicotine tolerance and dependence. In: Pratt, JA, ed. The biological basis of drug tolerance and dependence. London: Academic Press 121-151, 1991
American Psychiatric Association: Practice Guideline for the Treatment of Patients With Nicotine Dependence. Washington, DC: American Psychiatric Association, 1996 Orleans CT, Slade J (eds): Nicotine Addiction: Principles and Management. Oxford, England, Oxford University Press, 1993 Wonnacott S, Russell MAH, Stolerman IP, eds. Nicotine Psychopharmacology: molecular, cellular, and behavioural aspects. Oxford, England: Oxford Science Publications, 1990 Schuckit MA: Drug and Alcohol Abuse 4th edition (Chap. 12). New York, NY: Plenum Publishing Corp; 259-269, 1995 Galanter M, Kleber HD: American Psychiatric Press Textbook of Substance Abuse Treatment (Chap. 11) Washington D.C: American Psychiatric Association Press; 157-177, 1994 Schmitz JM, Schneider HG, Jarvik ME: Nicotine. In : Lowinsen JH, Ruiz P, Millman R, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook 3rd edition. Baltimore, ML: Williams & Wilkins; 276-294, 1997 Ziedonis DM, Wyatt SA, George TP: Current Issues in Nicotine Dependence and Treatment. In: Mc Cance-Katz EF, Kosten TR, eds. New Treatments for Chemical Addictions 1998: 1-34
Greenspan K, Edmands PE, Knocbel SB, Fisch C: Some effects of nicotine on cardiac automaticity, conduction, and inotropy. Arch Int Med 123 (6): 707-`12, 1969 Smoking and health: report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: U.S. Department of Health, Education and Welfare, 1964
Warner KE, Slade J, Sweanor DT: The emerging market for long-term nicotine maintenance. JAMA 278: 1087-1092, 1997 Slade J, Bero LA, Hanauer P, et al: Nicotine and addiction. The Brown and Williamson documents. JAMA 274 (3): 225-33, 1995 Henningfield JE, Kozlowski LT, Benowitz NL: A proposal to develop meaningful labeling for cigarettes. JAMA 272: 312-314, 1994
The diagnostic validity of melancholic major depression in a population-based sample of female twins. Arch of Gen Psy 54 (4): 299-304, 1997 Breslau N, Kilbey MM, Andreski P: Nicotine dependence and major depression. New evidence from a prospective investigation. Arch of Gen Psy 50 (1): 31-5, 1993 Breslau N, Kilbey MM, Andreski P: Nicotine dependence, major depression, and anxiety in toung adults. Arch of Gen Psy 48 (12): 1069-74, 1991 Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P: Major depression and stages of smoking. A longitudinal investigation. Arch of Gen Psy 55 (2): 161-6, 1998 Adler LE, Hoffer LD, Wiser A, et al: Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150: 1856-1861, 1993 Glassman AH: Cigarette smoking and its comorbidity. NIDA Mongraph Series No 97-4172. Rockville, MD, U.S. Dept. of Health and Human Services, 1997 Hughes JR: Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143: 993-997, 1986 Ziedonis DM, Kosten TYR, Glazer WM, et al: Nicotine dependence and schizophrenia. Hosp Community Psychiatry 45: 204-206, 1994 Ziedonis DM, George TP: Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull 23 (2): 247-254, 1997 Leonard S: Nicotinic receptor function in schizophrenia. Schizophr Bull 22: 431-445, 1996 Clemmey P: Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend 44: 123-132, 1997 Covey LS, Glassman AH, Stetner F: Major depression following smoking cessation. Am J Psychiatry 154: 263-265, 1997 Istvan J, Matarazzo JD: Tobacco, alcohol and caffeine use: a review of their interrelationships. Psychol Bull 95: 301-326, 1984 Bobo JK, Gilchrist LD, Schilling RF II, et al: Cigarette smoking cessation attempts by recovering alcoholics. Addict Behav 8:209-215, 1987 Batel P, Pessione F, Maitre C, et al: Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction 90: 977-980, 1995 Campbell BK, Wander N, Stark MJ, Holbert T: Treating cigarette smoking in drug-abusing clients. Journal of Substance Abuse Treatment. 12(2):89-94, 1995 Sterling RC, Gottheil E, Weinstein SP, Kurtz JW, Menduke H: The effect of a no-smoking policy on recruitment and retention in outpatient cocaine treatment. Journal of Addictive Diseases. 13(4):161-8, 1994.
U.S. Department of Health and Human Services: The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. DHHS Pub No CDC-88-8406. Rockville, MD, Office on Smoking and Health, 1988 Peto R: Mortality from smoking in developed countries 1950-2000. Oxford, England, Oxford University Press, 1994 Kawachi I, Colditz GA, Stampfer MJ, et al: Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Int Med 154 (2): 169-75, 1994 Mulcahy R: Influence of cigarette smoking on morbidity and mortality after myocardial infarction. Br Heart J 49: 410-415, 1983 Vliestra RE, Kronmal RA, Oberman A, et al: Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA 255: 1023-1027, 1986
Gourlay SG, Benowitz NL: The benefits of stopping smoking and the role of nicotine replacement therapy in older patients ( Review 125 refs). Drugs and Aging 9 (1): 8-23, 1996 Palmer JR, Rosenberg L, Shapiro S: Low yield cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med 320: 1569-1573, 1989 Ramirez AG, Gallion KJ: Nicotine dependence among blacks and Hispanics. In: Orleans CT, Slade J, eds. Nicotine addiction: Principles and management. New York: Oxford University Press 350-364, 1993 U.S. Centers for Disease Control and Prevention. Preventing tobacco use among young people: a report of the Surgeon General. MMWR 43 ( RR-4): 1-10, 1994 Lehtovirta P, Forss M, Rauramo I, Kariniemi V: Acute effects of nicotine on fetal heart rate variability. Br J Obstet Gynaecol 90: 710-715, 1983 Navarro HA, Seidler FJ, Whitmore WL, Slotkin TA: Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J Pharmacol Exp Ther 244: 940-944, 1988 Oncken CA, Hatsukami DK, Lupo VR, et al: Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther 59: 654-661, 1996
|